Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting

by Richard Kwizera, Alisat Sadiq, Jane Frances Ndyetukira, Elizabeth Nalintya, Darlisha Williams, Joshua Rhein, David R. Boulware, David B. Meya, on behalf of the COAT and ASTRO trial teams
Published 2020-08-01

Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection.

by Edward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, Andrew Akampurira, Tonny Luggya, Kiiza Kandole Tadeo, Katelyn A Pastick, Sarah C Bridge, Lillian Tugume, Reuben Kiggundu, Abdu K Musubire, Darlisha A Williams, Conrad Muzoora, Elizabeth Nalintya, Radha Rajasingham, Joshua Rhein, David R Boulware, David B Meya, Mahsa Abassi
Published 2018-01-01

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts

by Martha P. Montgomery, Noeline Nakasujja, Bozena M. Morawski, Radha Rajasingham, Joshua Rhein, Elizabeth Nalintya, Darlisha A. Williams, Kathy Huppler Hullsiek, Agnes Kiragga, Melissa A. Rolfes, Renee Donahue Carlson, Nathan C. Bahr, Kate E. Birkenkamp, Yukari C. Manabe, Paul R. Bohjanen, Jonathan E. Kaplan, Andrew Kambugu, David B. Meya, David R. Boulware, on behalf of the COAT and ORCAS Trial Teams
Published 2017-06-01